Tag: Major depressive disorder

Nano Formulations Targeting the Brain: Advances in Drug Delivery Systems for Cognitive Dysfunction in Depression

The item focuses on various nanotechnological approaches employed to overcome the ancestry-brain obstacle (BBB) and facilitate targeted drug childbirth to the brain, that is the crux in the management of intelligent disorders. Major depressive disorder is a widespread neuropsychiatric condition that frequently goes unnoticed and undiagnosed, specifically in underserved...
Read More

Comparative Efficacy and Safety of Augmentation Therapy with Ziprasidone versus Quetiapine in Patients of Major Depressive Disorder on Escitalopram| Chapter 4 | Current Aspects in Pharmaceutical Research and Development Vol.9

Many patients with major depressive disorder (MDD) do not respond to traditional antidepressant medication or only respond partially. As a result, augmentation therapy with atypical antipsychotic medications is required in many patients, boosting antidepressant effect and extending partial remission. In patients with MDD, this trial compared augmentation therapy with...
Read More